This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US FTC loss in Meta monopolization suit a win for consumers, Cato says

( November 18, 2025, 22:00 GMT | Official Statement) -- MLex Summary: The US Federal Trade Commission's loss in its monopolization suit against Meta over the company's acquisitions of Instagram and WhatsApp is a win for consumers and innovators, Cato Institute senior fellow Jennifer Huddleston said in a statement. The decision from a federal court, which found that the FTC failed to prove its case that the acquisitions were illegal, "illustrates that the courts are still committed to protecting consumer welfare rather than the use of antitrust enforcement to serve policy goals that it was not designed for and that do not reflect the market consumers actually experience," Huddleston said. The FTC's loss also indicates that a more subjective approach to antitrust that shifts the focus away from consumers "is unlikely to be adopted by the courts in the future," the statement said.Statement follows below: ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections